The Transitions Study recruited a heterogeneous cohort at baseline in relation to the nature and severity of mental health problems and levels of functional impairment. The variation in clinical presentations within the cohort, from mild, through moderate to severe levels of psychopathology and impairment, increases the likelihood of the Transitions Study ultimately being able to achieve its aims of empirically testing a clinical staging model for mental disorders.
The metal–organic frameworks (MOFs) UiO-66-NH2 and HKUST-1 were adhered to chemically inert polypropylene
(PP)
fibrous mats with poly(ether-block-amide), aka PEBA
or PeBax, using a phase inversion technique. Two types of PeBax were
used to investigate the effects of a hydrophilic vs hydrophobic treatment
on uptake and permeation properties of the chemical warfare agent
simulant 2-chloroethyl ethyl sulfide (CEES). Furthermore, the underlying
PP fiber density was altered to understand CEES permeation properties.
It was found that using the hydrophobic PeBax 2533 and a higher fiber
density led to better barrier properties, with the best material providing
∼250 min protection to a permeation rate of 0.1 μg/min/cm2 in comparison to ∼150 min for the activated carbon
fiber Stedcarb. CEES uptake ranged from ∼1.0 to 2.4 mol/kg
for composites in comparison to 3.6 mol/kg for the pure MOF. Furthermore,
the technique allowed for incorporation of different MOFs, and even
a mixture of MOFs, on the same fiber substrate. Finally, the PeBax
formulation was able to stabilize HKUST-1 against moisture, potentially
opening the door for applications of this MOF in high-humidity environments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.